Literature DB >> 20824536

Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.

Min-Chien Tu1, Chi-Wei Huang, Nai-Ching Chen, Wen-Neng Chang, Chun-Chung Lui, Chih-Feng Chen, Ching Chen, Ya-Ling Wang, Yu-Ting Lin, Chiung-Chih Chang.   

Abstract

PURPOSE: White matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are commonly found in Alzheimer's disease (AD) and may contribute to cognitive impairment. Plasma total homocysteine (tHcy) had also been linked with cognitive decline in AD. We examined the relationship among change of cognition, tHcy level, and WMHs on MRI in AD patients with a follow-up periods of 6 months.
METHODS: AD patients with normal creatinine level and initial clinical dementia rating (CDR) of 1 to 2 were enrolled. tHcy and biochemistry tests related to cerebral vascular risk factors were collected. WMHs were measured on MRI fluid attenuated inverse recovery sequence and classified into deep white matter hyperintensities (DWMHs) and periventricular white matter hyperintensities (PWMHs) by visual rating scale. Neuropsychological tests including cognitive ability screening instrument (CASI), mini-mental state examination (MMSE) converted from CASI scores and CDR were collected twice during the follow- up period of 6 months.
RESULTS: Ninety-two AD patients, 30 men and 62 women completed the study while the tHcy level was not significantly different between AD and age matched controls. tHcy level showed no correlation with CASI or MMSE score, at either the first or second examination. tHcy showed positive correlation with decline of CASI total score and abstract thinking (both p<0.01) but not in MMSE decline. There was no significant correlation between neuropsychiatric assessment and WMHs, but the decline of abstract thinking score was related to frontal PWMHs (R square=0.237, p=0.007).
CONCLUSION: tHcy might be associated with rapid cognitive decline in AD after a 6-month follow-up period and the effect might not be directly through WMHs. tHcy level correlated with greater WMHs in the trigone area although greater lesion load by MRI was in the occipital lobe.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824536

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  13 in total

1.  Genetic effect of MTHFR C677T polymorphism on the structural covariance network and white-matter integrity in Alzheimer's disease.

Authors:  Yu-Tzu Chang; Shih-Wei Hsu; Shih-Jen Tsai; Ya-Ting Chang; Chi-Wei Huang; Mu-En Liu; Nai-Ching Chen; Wen-Neng Chang; Jung-Lung Hsu; Chen-Chang Lee; Chiung-Chih Chang
Journal:  Hum Brain Mapp       Date:  2017-03-25       Impact factor: 5.038

2.  Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells.

Authors:  Preethi S Ganapathy; Richard L Perry; Amany Tawfik; Robert M Smith; Elizabeth Perry; Penny Roon; B Renee Bozard; Yonju Ha; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

3.  A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.

Authors:  Michele L Mietus-Snyder; Mark K Shigenaga; Jung H Suh; Swapna V Shenvi; Ashutosh Lal; Tara McHugh; Don Olson; Joshua Lilienstein; Ronald M Krauss; Ginny Gildengoren; Joyce C McCann; Bruce N Ames
Journal:  FASEB J       Date:  2012-05-01       Impact factor: 5.191

Review 4.  Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.

Authors:  Vandana Rai
Journal:  Metab Brain Dis       Date:  2016-03-08       Impact factor: 3.584

5.  Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine.

Authors:  Jianying Sun; Shiling Wen; Jing Zhou; Shuling Ding
Journal:  J Clin Lab Anal       Date:  2016-11-07       Impact factor: 2.352

6.  Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.

Authors:  Hongyuan Wei; Yunjiao Zhu; Tianli Wang; Xueqing Zhang; Kexin Zhang; Zhihua Zhang
Journal:  J Neural Transm (Vienna)       Date:  2021-06-11       Impact factor: 3.575

7.  Domain specific changes in cognition at high altitude and its correlation with hyperhomocysteinemia.

Authors:  Vijay K Sharma; Saroj K Das; Priyanka Dhar; Kalpana B Hota; Bidhu B Mahapatra; Vivek Vashishtha; Ashish Kumar; Sunil K Hota; Tsering Norboo; Ravi B Srivastava
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  Clinical Significance of Cerebrovascular Biomarkers and White Matter Tract Integrity in Alzheimer Disease: Clinical correlations With Neurobehavioral Data in Cross-Sectional and After 18 Months Follow-ups.

Authors:  Ming-Kung Wu; Yan-Ting Lu; Chi-Wei Huang; Pin-Hsuan Lin; Nai-Ching Chen; Chun-Chung Lui; Wen-Neng Chang; Chen-Chang Lee; Ya-Ting Chang; Sz-Fan Chen; Chiung-Chih Chang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer's disease.

Authors:  Chi-Wei Huang; Shih-Wei Hsu; Shih-Jen Tsai; Nai-Ching Chen; Mu-En Liu; Chen-Chang Lee; Shu-Hua Huang; Weng-Neng Chang; Ya-Ting Chang; Wan-Chen Tsai; Chiung-Chih Chang
Journal:  J Neuroinflammation       Date:  2017-01-18       Impact factor: 8.322

10.  The Impact of Admission Diagnosis on Recurrent or Frequent Hospitalizations in 3 Dementia Subtypes: A Hospital-Based Cohort in Taiwan with 4 Years Longitudinal Follow-Ups.

Authors:  Chiung-Chih Chang; Pin-Hsuan Lin; Ya-Ting Chang; Nai-Ching Chen; Chi-Wei Huang; Chun-Chung Lui; Shu-Hua Huang; Yen-Hsiang Chang; Chen-Chang Lee; Wei-An Lai
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.